Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation

被引:472
作者
Taylor, KR
Gallo, RL
机构
[1] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA
[2] VA Med Ctr, San Diego, CA USA
关键词
heparan sulfate; chondroitin sulfate; dermatan sulfate; hyaluronan;
D O I
10.1096/fj.05-4682rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Glycosaminoglycans, linear carbohydrates such as heparan sulfate and hyaluronan, participate in a variety of biological processes including cell-matrix interactions and activation of chemokines, enzymes and growth factors. This review will discuss progress in immunology and the science of wound repair that has revealed the importance of glycosaminoglycans, and their proteoglycans, in the inflammatory process. Heparan sulfate enables growth factor function and modifies enzyme/inhibitor functions, such as antithrombin III and heparin cofactor II. Heparan sulfate also interacts with cytokines/chemokines and participates in leukocyte selectin binding to promote the recruitment of leukocytes. Chondroitin sulfate/dermatan sulfate regulates growth factor activity and is an alternate modulator of heparin cofactor II. In addition, dermatan sulfate induces ICAM-1 expression on endothelial cells and also recruits leukocytes via selectin interactions. Hyaluronan alternatively participates in leukocyte recruitment via interaction with CD44, while activating various inflammatory cells, such as macrophages, through CD44-dependent signaling. Hyaluronan also signals through Toll-like receptor 4 to induce dendritic cell maturation and promote cytokine release by dendritic cells and endothelial cells. Taken together, the field of glycosaminoglycan biology provides new clues and explanations of the process of inflammation and suggests new therapeutic approaches to human disease.-Taylor, K. R., Gallo, R. L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation.
引用
收藏
页码:9 / 22
页数:14
相关论文
共 129 条
[1]
Serglycin is essential for maturation of mast cell secretory granule [J].
Åbrink, M ;
Grujic, M ;
Pejler, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) :40897-40905
[2]
Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene [J].
Akama, TO ;
Nishida, K ;
Nakayama, J ;
Watanabe, H ;
Ozaki, K ;
Nakamura, T ;
Dota, A ;
Kawasaki, S ;
Inoue, Y ;
Maeda, N ;
Yamamoto, S ;
Fujiwara, T ;
Thonar, EJMA ;
Shimomura, Y ;
Kinoshita, S ;
Tanigami, A ;
Fukuda, MN .
NATURE GENETICS, 2000, 26 (02) :237-241
[3]
Mice deficient in small leucine-rich proteoglycans:: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases [J].
Ameye, L ;
Young, MF .
GLYCOBIOLOGY, 2002, 12 (09) :107R-116R
[4]
Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia [J].
Arikawa-Hirasawa, E ;
Le, AH ;
Nishino, I ;
Nonaka, I ;
Ho, NC ;
Francomano, CA ;
Govindraj, P ;
Hassell, JR ;
Devaney, JM ;
Spranger, J ;
Stevenson, RE ;
Iannaccone, S ;
Dalakas, MC ;
Yamada, Y .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (05) :1368-1375
[5]
Dyssegmental dysplasia, Silverman-Handmaker type: Unexpected role of perlecan in cartilage development [J].
Arikawa-Hirasawa, E ;
Wilcox, WR ;
Yamada, Y .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (04) :254-257
[6]
Perlecan is essential for cartilage and cephalic development [J].
Arikawa-Hirasawa, E ;
Watanabe, H ;
Takami, H ;
Hassell, JR ;
Yamada, Y .
NATURE GENETICS, 1999, 23 (03) :354-358
[7]
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans [J].
Bame, KJ .
GLYCOBIOLOGY, 2001, 11 (06) :91R-98R
[8]
Proteoglycans in the developing brain: New conceptual insights for old proteins [J].
Bandtlow, CE ;
Zimmermann, DR .
PHYSIOLOGICAL REVIEWS, 2000, 80 (04) :1267-1290
[9]
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses [J].
Beg, AA .
TRENDS IN IMMUNOLOGY, 2002, 23 (11) :509-512
[10]
Fetal wound healing: Current biology [J].
Bullard, KM ;
Longaker, MT ;
Lorenz, HP .
WORLD JOURNAL OF SURGERY, 2003, 27 (01) :54-61